Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma.
about
Biological response modifiers in cancerA phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.Alemtuzumab for B-cell chronic lymphocytic leukemia.Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatmImmunotherapy targets in pediatric cancer.Targeted therapy for hematologic malignancies.Effect of alemtuzumab on intestinal intraepithelial lymphocytes and intestinal barrier function in cynomolgus modelPilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
P2860
Q24685049-68DC7A75-3502-4817-A218-F07B8EC0D0AFQ33337233-E004EEA1-E4BE-48A5-A6E9-E53B2DE1EFC7Q33380135-7E137F0E-48F0-4861-8DB0-7F19D249D701Q35566338-63F1524F-5EDC-42F9-9D53-535C92207E4FQ35971029-6A670B58-0422-495A-98FA-F4CB937D92BFQ36108610-F88B667C-30DD-4C20-97AE-972793F41E5FQ36807186-70B69EE6-2383-437C-9F35-C46D4BA12DB7Q46817686-DF96F09E-7BB7-43FD-BFC7-C8A34570B85D
P2860
Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Immunosuppressive toxicity of ...... recurrent low grade lymphoma.
@en
type
label
Immunosuppressive toxicity of ...... recurrent low grade lymphoma.
@en
prefLabel
Immunosuppressive toxicity of ...... recurrent low grade lymphoma.
@en
P2093
P2860
P1433
P1476
Immunosuppressive toxicity of ...... recurrent low grade lymphoma.
@en
P2093
P2860
P304
P356
10.3109/10428199609045717
P577
1996-12-01T00:00:00Z